Nice to see GSK seems to be in the forefront of the fight and "is not wedded to any one particular technology solution. We keep all options under review and are willing to consider engaging in pilot studies designed to road test new programmes for applicability in different scenarios."
Certainly sounds like a potential partner... hopefully we'll learn more in the coming weeks.
News 
Market Data 
Discover 
